Conditions: Anemia, Iron-Deficiency Kidney Failure, Chronic
Keywords: Iron deficiency Anemia Chronic kidney disease Sodium Ferric Gluconate Anemia, Iron-Deficiency/drug therapy/etiology Kidney Failure, Chronic/blood/complications/therapy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 89
Healthy volunteers: no

Brief summary:
This study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate (a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease patients who are not receiving erythropoietic agents (hormones that stimulate the bone marrow to make more red blood cells).

Detailed description:

Arms:
arm 1: Sodium ferric gluconate arm 2: ferrous sulfate

Interventions: intervention 1: Sodium Ferric Gluconate Complex in Sucrose Injection intervention 2: Ferrous sulfate tablets
Intervention descriptions: intervention 1: Sodium Ferric Gluconate Complex in Sucrose Injection (Ferrlecit®), 250 mg IV weekly for 4 weeks intervention 2: ferrous sulfate, 325 mg oral, three times daily for 6 weeks

Protocol document: